U.S. Department of Health and Human Services

Endocrine Tumors of the Pancreas

Pancreatic endocrine tumors (PETs) or pancreatic neuroendocrine tumors (PNETs) account for 1 percent to 10 percent of tumors arising in the pancreas, and represent a wide array of tumors that are mostly characterized by their secreted hormone, when functional.

The Endocrine Tumors of the Pancreas program supports research to understand the cellular and molecular physiology and pathophysiology of both functional and nonfunctional pancreatic tumors.  Research is aimed at identifying risk factors and diagnostic/prognostic molecular and laboratory markers, and includes studies on the epidemiology, clinical manifestations, and treatment of PETs.​

 NIDDK Staff

Dana K. Andersen, M.D.Observational and Investigational Clinical Research; Biomedical Devices, Surgical Interventions, and Medications
Jose Serrano, M.D., Ph.D.Liver Bioengineering and Biotechnology; Drug-induced Liver Disease; Gastrointestinal Neuroendocrinology; Exocrine Pancreas; Pancreatitis


 Related Funding Opportunities

Posted DateTitleFull Announcement
8/7/2015Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp) (Summary) PA-15-321
7/17/2015Mouse Metabolic Phenotyping Centers Consortium (U2C) (Summary) RFA-DK-15-010
6/29/2015Exploration of the Roles of Brown and Beige Adipose Tissue in Humans (R01) (Summary) RFA-DK-15-031
6/24/2015Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02) (Summary) PAR-15-286
6/24/2015Opportunities for Collaborative Research at the NIH Clinical Center (U01) (Summary) PAR-15-287
View More Funding Opportunities

The resources listed below include reagents, data, protocols, etc. If you would like to utilize any of these resources, contact the person associated with the resource.


 Research Resources

Resource NameDescription
Action to Control Cardiovascular Disease Risk in Diabetes Follow-up Study
ACCORDION (sponsored by NHLBI) is a prospective, observational follow-up study of at least 8000 participants who were treated and followed in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial.  Treatment in ACCORD ended in 2009 and…
Diabetic Complications Consortium
The goal of the NIDDK-sponsored Diabetic Complications Consortium (DiaComp) is to foster communication and collaboration between investigator communities involved in complications research.  Toward this goal, DiaComp: (1) sponsors annual meetings in…
NIDDK Information Network

The NIDDK Information Network (dkNET), serves the needs of basic and clinical investigators by providing seamless access to large pools of data relevant to the mission of NIDDK. The goal of dkNET is to develop a community-based network for…

NIDDK Repository for Biosamples and Data

Supports Data, Biosample, and Genetic Repositories to increase the impact of current and previously funded NIDDK studies by making their data and biospecimens available to the broader scientific community. These Repositories enable scientists not…

Epidemiology of Diabetes Interventions and Complications

An observational study examining the risk factors associated with the long-term complications of type 1 diabetes. The study began in 1994 and follows the 1441 participants previously enrolled in the Diabetes Control and Complications Trial (DCCT).

View Additional Research Resources


 NIDDK Active Trials in Pancreatic Disease

View related clinical trials from ClinicalTrials.gov.


 Related Study Sections

​​Study sections conduct initial peer review of applications in a designated scientific area. View related study sections from the NIH's Center for Scientific Review.